191 related articles for article (PubMed ID: 38673756)
1. Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers.
Aparicio AM; Shen L; Tapia EL; Lu JF; Chen HC; Zhang J; Wu G; Wang X; Troncoso P; Corn P; Thompson TC; Broom B; Baggerly K; Maity SN; Logothetis CJ
Clin Cancer Res; 2016 Mar; 22(6):1520-30. PubMed ID: 26546618
[TBL] [Abstract][Full Text] [Related]
2. Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer.
Lu D; Sinnott JA; Valdimarsdóttir U; Fang F; Gerke T; Tyekucheva S; Fiorentino M; Lambe M; Sesso HD; Sweeney CJ; Wilson KM; Giovannucci EL; Loda M; Mucci LA; Fall K
Clin Cancer Res; 2016 Feb; 22(3):765-772. PubMed ID: 26490316
[TBL] [Abstract][Full Text] [Related]
3. Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness.
Schiewer MJ; Knudsen KE
Urol Clin North Am; 2021 Aug; 48(3):339-347. PubMed ID: 34210489
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer.
Martin-Caraballo M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
[TBL] [Abstract][Full Text] [Related]
5. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
Akamatsu S; Inoue T; Ogawa O; Gleave ME
Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
[TBL] [Abstract][Full Text] [Related]
7. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.
Brown NE; Paluch AM; Nashu MA; Komurov K; Waltz SE
Neoplasia; 2018 Sep; 20(9):917-929. PubMed ID: 30121008
[TBL] [Abstract][Full Text] [Related]
8. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract][Full Text] [Related]
9. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of REST Represses the Epithelial-Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells.
Indo S; Orellana-Serradell O; Torres MJ; Castellón EA; Contreras HR
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542313
[TBL] [Abstract][Full Text] [Related]
11. Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms.
Gujrati H; Ha S; Wang BD
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370750
[TBL] [Abstract][Full Text] [Related]
12. IL-6 evoked biochemical changes in prostate cancer cells.
Bennett JL; Jackson BN; Miller RJ; Tsui H; Martin-Caraballo M
Cytokine; 2023 Jan; 161():156079. PubMed ID: 36372008
[TBL] [Abstract][Full Text] [Related]
13. Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53.
Brown DW; Beatty PH; Lewis JD
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358595
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel.
Jiménez N; Reig Ò; Marín-Aguilera M; Aversa C; Ferrer-Mileo L; Font A; Rodriguez-Vida A; Climent MÁ; Cros S; Chirivella I; Domenech M; Figols M; González-Billalabeitia E; Jiménez Peralta D; Rodríguez-Carunchio L; García-Esteve S; Garcia de Herreros M; Ribal MJ; Prat A; Mellado B
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230681
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
